Your session is about to expire
← Back to Search
Optokinetic Stimulation
OKS for the Treatment of Hemispatial Neglect
N/A
Waitlist Available
Led By Chun Lim, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 1 hour of oks
Awards & highlights
No Placebo-Only Group
Summary
This trial will help researchers understand how optokinetic stimulation (a therapy involving moving patterns) can help patients with hemispatial neglect (a disorder where patients have difficulty attending to objects on the left side following a stroke).
Eligible Conditions
- Hemispatial neglect
- Unilateral Neglect
- Sensory Neglect
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 1 hour of oks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 1 hour of oks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Hemispatial neglect scores
Effect of OKS on vision
Secondary study objectives
Changes in secondary hemispatial neglect scores
Effect of OKS on gait
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: Safety and efficacy studyExperimental Treatment1 Intervention
Randomized study assessing the safety and efficacy of OKS in treating hemispatial neglect
Group II: Optimization of OKSExperimental Treatment1 Intervention
Crossover study examining various OKS protocols on improving symptoms of hemispatial neglect
Group III: OKS and gaitExperimental Treatment1 Intervention
Effect of OKS on gait and balance
Group IV: Effect of repetitive stimulationExperimental Treatment1 Intervention
Benefits of daily, repetitive OKS in treating hemispatial neglect
Find a Location
Who is running the clinical trial?
National Eye Institute (NEI)NIH
558 Previous Clinical Trials
1,408,471 Total Patients Enrolled
Beth Israel Deaconess Medical CenterLead Sponsor
861 Previous Clinical Trials
12,932,826 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,339 Previous Clinical Trials
14,881,631 Total Patients Enrolled
Chun Lim, MDPrincipal Investigator - Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center, Beth Israel Deaconess Medical Center-Departmet of Neurology